Chronic lipopolysaccharide exposure induces cognitive dysfunction without affecting BDNF expression in the rat hippocampus

Adam, 2013, Sepsis-induced brain dysfunction, Expert Rev Anti Infect Ther, 11, 211, 10.1586/eri.12.159

Zampieri, 2011, Sepsis-associated encephalopathy: not just delirium, Clinics (Sao Paulo), 66, 1825, 10.1590/S1807-59322011001000024

Guan, 2006, Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats, Brain Behav Immun, 20, 64, 10.1016/j.bbi.2005.04.005

Suzumura, 2006, Roles of glia-derived cytokines on neuronal degeneration and regeneration, Ann NY Acad Sci, 1088, 219, 10.1196/annals.1366.012

Wang, 2011, LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats, Prog Neuropsychopharmacol Biol Psychiatry, 35, 1831, 10.1016/j.pnpbp.2011.07.004

Deng, 2012, Lipopolysaccharide induces paired immunoglobulin-like receptor B (PirB) expression, synaptic alteration, and learning-memory deficit in rats, Neuroscience, 209, 161, 10.1016/j.neuroscience.2012.02.022

Richwine, 2009, Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide, Brain Behav Immun, 23, 794, 10.1016/j.bbi.2009.02.020

Sparkman, 2006, Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers, J Neurosci, 26, 10709, 10.1523/JNEUROSCI.3376-06.2006

Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat Rev Neurosci, 9, 46, 10.1038/nrn2297

Smith, 2012, Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression, Cytokine, 58, 384, 10.1016/j.cyto.2012.02.016

Krzyszton, 2008, Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation, Am J Physiol Regul Integr Comp Physiol, 295, R1109, 10.1152/ajpregu.90302.2008

Johnston, 2011, Assessing the contribution of inflammation in models of Alzheimer’s disease, Biochem Soc Trans, 39, 886, 10.1042/BST0390886

Kaster, 2012, Depressive-like behavior induced by tumor necrosis factor-α in mice, Neuropharmacology, 62, 419, 10.1016/j.neuropharm.2011.08.018

Mansur, 2012, Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages, Psychiatry Clin Neurosci, 66, 247, 10.1111/j.1440-1819.2012.02354.x

Pizza, 2011, Neuroinflamm-aging and neurodegenerative diseases: an overview, CNS Neurol Disord Drug Targets, 10, 621, 10.2174/187152711796235014

Magaki, 2007, Increased production of inflammatory cytokines in mild cognitive impairment, Exp Gerontol, 42, 233, 10.1016/j.exger.2006.09.015

Oral, 2012, Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder, Brain Res Bull, 88, 454, 10.1016/j.brainresbull.2012.03.005

Zhang, 2012, Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia, Psychopharmacology (Berl), 222, 277, 10.1007/s00213-012-2643-y

D’Hooge, 2001, Applications of the Morris water maze in the study of learning and memory, Brain Res Brain Res Rev, 36, 60, 10.1016/S0165-0173(01)00067-4

Solov’eva, 2013, Marine compounds with therapeutic potential in gram-negative sepsis, Mar Drugs, 11, 2216, 10.3390/md11062216

Skelly, 2013, A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, TNF-α and IL-6 challenges in C57BL/6 mice, PLoS One, 8, e69123, 10.1371/journal.pone.0069123

Shaw, 2001, Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus, Behav Brain Res, 124, 47, 10.1016/S0166-4328(01)00232-7

Leung, 2013, Inflammatory proteins in plasma are associated with severity of Alzheimer’s disease, PLoS One, 8, e64971, 10.1371/journal.pone.0064971

Reale, 2004, Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines, J Neuroimmunol, 148, 162, 10.1016/j.jneuroim.2003.11.003

Hsu, 1998, Expression pattern of synucleins (non-Abeta component of Alzheimer’s disease amyloid precursor protein/alpha-synuclein) during murine brain development, J Neurochem, 71, 338, 10.1046/j.1471-4159.1998.71010338.x

Nguyen, 2006, Views on amyloid hypothesis and secretase inhibitors for treating Alzheimer’s disease: progress and problems, Curr Pharm Des, 12, 4295, 10.2174/138161206778792976

Yan, 1997, Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system, Neuroscience, 78, 431, 10.1016/S0306-4522(96)00613-6

Lapchak, 1993, Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation, Neuroscience, 53, 297, 10.1016/0306-4522(93)90196-M

Maher, 2004, Increased IL-1beta in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase, Neurobiol Aging, 25, 795, 10.1016/j.neurobiolaging.2003.08.007

Taishi, 2008, Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo, Brain Res, 1226, 89, 10.1016/j.brainres.2008.05.067

Schnydrig, 2007, Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain, Neurosci Lett, 429, 69, 10.1016/j.neulet.2007.09.067